Analyst Price Targets — ICL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 10, 2026 12:23 pm | — | Morgan Stanley | $5.75 | $5.40 | TheFly | ICL price target raised to $5.75 from $5.60 at Morgan Stanley |
| July 27, 2026 10:31 am | — | Barclays | $6.00 | $5.28 | TheFly | ICL price target lowered to $6 from $7 at Barclays |
| May 28, 2026 12:37 pm | — | Morgan Stanley | $5.80 | $6.73 | TheFly | ICL price target raised to $5.80 from $5.40 at Morgan Stanley |
| May 20, 2026 11:03 am | Joel Jackson | BMO Capital | $6.50 | $6.49 | StreetInsider | Israel Chemicals Ltd (ICL) PT Raised to $6.50 at BMO Capital |
| May 18, 2026 9:43 am | — | Barclays | $7.00 | $6.41 | TheFly | ICL price target raised to $7 from $6 at Barclays |
| January 14, 2026 10:19 am | Vincent Andrews | Morgan Stanley | $6.15 | $5.41 | TheFly | ICL price target raised to $6.15 from $5.80 at Morgan Stanley |
| May 16, 2024 6:15 am | Alexander Laurence | Jefferies | $5.00 | $4.79 | StreetInsider | Israel Chemicals Ltd (ICL) PT Lowered to $5 at Jefferies |
| April 8, 2024 1:31 pm | Vincent Andrews | Morgan Stanley | $5.20 | $5.11 | StreetInsider | Israel Chemicals Ltd (ICL) PT Lowered to $5.20 at Morgan Stanley |
| January 11, 2023 8:33 am | — | Morgan Stanley | $8.50 | $7.45 | Benzinga | Morgan Stanley Maintains Equal-Weight on ICL Group, Lowers Price Target to $8.5 |
| July 28, 2022 8:13 am | — | BMO Capital | $11.00 | $9.03 | Benzinga | BMO Capital Maintains Market Perform on ICL Group, Lowers Price Target to $11 |
Latest News for ICL
ICL Group (NYSE: ICL - Get Free Report) and Westaim (OTCMKTS:WEDXF - Get Free Report) are both materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Volatility and Risk ICL Group has a beta of
ICL Group NYSE: ICL reported higher second-quarter 2026 sales, earnings and cash flow, supported by stronger prices for potash, bromine and phosphate products. The company also outlined plans to reorganize its reporting structure in 2027 and introduced a cost-transformation program targeting more than $350 million in annual EBITDA improvements by the end of 2028.
Amundi raised its position in shares of ICL Group Ltd. (NYSE: ICL) by 49.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,115,720 shares of the basic materials company's stock after acquiring an additional 370,457 shares during the period. Amundi
ICL Group Ltd (ICL) Q2 2026 Earnings Call Transcript
ICL Group (ICL) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.09 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ICL.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.